LatticePoint Experience
Therapeutic and Global Experience
LatticePoint has been working with clients and major industry players for decades ranging from rare diseases, medical devices and a range of therapeutic areas. Our clients trust our world-class team of market access leader’s experience in the sciences, industry, venture capital and negotiations assess your product in the marketplace.
We have helped companies of all sizes and situations
Big Pharma
Emerging biopharma
Investors
BD/In-licensing teams
A range of therapeutic areas
Rare Diseases and/or Orphan Designation:
Oncology
- Relapse/refractory neuroblastoma
- Acute lymphoblastic/myeloid leukemia
Hematology
- Haemophilia-A and –B
- Beta-thalassemia (gene therapy)
- Hereditary Angioedema
Autoimmune diseases
- Idiopathic thrombocytopenic purpura (ITP)
- Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID – gene therapy)
Endocrinology
- Primary hyperparathyroidism
- Hypoparathyroidism
Others
- Cystic fibrosis
- Homozygous familial hypercholesterolaemia (oral, biologic)
- Severe veno-occlusive disease
- Duchenne Muscular Dystrophy (3-products)
- Lysomsomal Storage Disorders (Gaucher, Fabry – biologic, oral)
- Pompe Disease (biologic)
- Hunner’s lesions (interstitial cystitis)
- Calciphylaxis
Non-orphan Therapeutic Areas
Medicines
- Alzeimer’s disease
- Parkinson’s disease
- Multiple sclerosis
- Psoriasis (oral, biologic)
- Rheumatoid arthritis (biologic)
- Oncology, including bladder, pancreatic, breast, ovarian, neuroblastoma
- Hereditary ATTR amyloidosis (biologic)
- wet-AMD, Retinal Vein Occlusion, Diabetic Macular Edema
- Acute, chronic Pain / Uremic Pruritus
- Systemic Lupus Erythematosus
- Bronchiolitis Obliterans
- Stroke Prevention/Thrombosis
- Pain (Neuropathic, osteoarthritis, opioid, NGFi)
- Antibiotics
- Hepatitis C
Medical devices/Non-drug intervention
- Endomicroscopy system
- Wound care dressings
- Laser Cataract Surgery
- Fertility products
- Nutrition products
This is a non-exhaustive list of the therapeutic areas we have worked on.
Global negotiation experience
At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, HTA bodies and EMA for early access, give feedback on clinical program design, and conduct in-country reimbursement negotiations in key markets around the world. We also retain a Global Payer Panel for market research.
